Results 191 to 200 of about 74,493 (218)

Goodpasture's (Anti-GBM) Disease and HLA-DRw2

New England Journal of Medicine, 1981
S I, Perl, B A, Pussell, J A, Charlesworth, G J, Macdonald, M, Wolnizer   +4 more
openaire   +2 more sources

IgA-mediated anti-GBM disease

2016
Professor Galešić Ljubanović presented in slide seminar a case of IgA-mediated anti-GBM disease.
openaire  

In Reply to “‘Atypical’ Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?”

American Journal of Kidney Diseases
Chauveau, Bertrand, Gibier, Jean-Baptiste, Rabant, Marion   +2 more
openaire   +2 more sources

A case of relapsing anti-GBM disease secondary to alemtuzumab therapy

CEN Case Reports, 2023
Saskia M Leibowitz
exaly  

Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease

Clinical Immunology, 2023
Natasha M Rogers, David C H Harris
exaly  

Antibodies: Still Important in Anti-GBM Disease

Nephron Clinical Practice, 2004
openaire   +2 more sources

Anti GBM Disease: A Case Report

B40. AUTOIMMUNE LUNG DISEASE CASE REPORTS, 2019
N. Jiwa, W. Magno, U. Ibe, M. Rho, W. Frederick, D. Osahan   +5 more
openaire   +1 more source

Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease

Kidney International, 2003
Alan D Salama, Raghu Kalluri, Mohamed H Sayegh   +2 more
exaly  

Recurrence of Anti-GBM Disease: An Epiphenomenon?

Journal of the American Society of Nephrology, 2020
openaire   +1 more source

The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHα3(IV)NC1 is associated with disease severity

Human Immunology, 2009
Zhao Cui, Ming-Hui Zhao
exaly